Literature DB >> 16263756

The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome.

Etienne Caron1, Renée Charbonneau, Gabrielle Huppé, Sylvie Brochu, Claude Perreault.   

Abstract

Proteins show drastic discrepancies in their contribution to the collection of self-peptides that shape the repertoire of CD8 T cells (MHC I self-immunopeptidome). To decipher why selected proteins are the foremost sources of MHC I-associated self-peptides, we chose to study SIMP/STT3B because this protein generates very high amounts of MHC I-associated peptides in mice and humans. We show that the endoplasmic reticulum (ER)-associated degradation pathway and MHC I processing intersect at SIMP/STT3B. Relevant key features of SIMP/STT3B are its lysine-rich region, its propensity to misfold and its location in the ER membrane in close proximity to the immunoproteasome. Moreover, we show that coupling to SIMP/STT3B can be used to foster MHC I presentation of a selected peptide, here the ovalbumin peptide SIINFEKL. These data yield novel insights into relations between the cell proteome and the MHC I immunopeptidome. They suggest that the contribution of a given protein to the MHC I immunopeptidome results from the interplay of at least three factors: the presence of degrons (degradation signals), the tendency of the protein to misfold and its subcellular localization. Furthermore, they indicate that substrates of the ER-associated degradation pathway may have a prominent imprint on the MHC I self-immunopeptidome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263756     DOI: 10.1093/intimm/dxh336

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

2.  Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Authors:  Danielle de Verteuil; Tara L Muratore-Schroeder; Diana P Granados; Marie-Hélène Fortier; Marie-Pierre Hardy; Alexandre Bramoullé; Etienne Caron; Krystel Vincent; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Mol Cell Proteomics       Date:  2010-05-19       Impact factor: 5.911

Review 3.  The use of mouse models to better understand mechanisms of autoimmunity and tolerance.

Authors:  Fumi Miyagawa; Jan Gutermuth; Hong Zhang; Stephen I Katz
Journal:  J Autoimmun       Date:  2010-07-23       Impact factor: 7.094

Review 4.  Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.

Authors:  Luis C Antón; Jonathan W Yewdell
Journal:  J Leukoc Biol       Date:  2014-02-14       Impact factor: 4.962

5.  Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome.

Authors:  Ingrid M M Schellens; Ilka Hoof; Hugo D Meiring; Sanne N M Spijkers; Martien C M Poelen; Jacqueline A M van Gaans-van den Brink; Kees van der Poel; Ana I Costa; Cecile A C M van Els; Debbie van Baarle; Can Kesmir
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

Review 6.  Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.

Authors:  Etienne Caron; Daniel J Kowalewski; Ching Chiek Koh; Theo Sturm; Heiko Schuster; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2015-12       Impact factor: 5.911

7.  ER stress affects processing of MHC class I-associated peptides.

Authors:  Diana P Granados; Pierre-Luc Tanguay; Marie-Pierre Hardy; Etienne Caron; Danielle de Verteuil; Sylvain Meloche; Claude Perreault
Journal:  BMC Immunol       Date:  2009-02-16       Impact factor: 3.615

8.  The MHC class I peptide repertoire is molded by the transcriptome.

Authors:  Marie-Hélène Fortier; Etienne Caron; Marie-Pierre Hardy; Grégory Voisin; Sébastien Lemieux; Claude Perreault; Pierre Thibault
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.